If I may, that's the idea of a specific outreach to veterans who may have been affected. This is a consistent request by veterans groups internationally. We've seen this request articulated in Ireland, in the United Kingdom, in the United States, and in Australia.
I think the implementation of that kind of outreach program is very helpful. It would demonstrate acknowledgement of the problem by the government, either by the military or by the Department of Veterans Affairs. This is critical. It has been critical in the United States where for many years mefloquine was sort of like a Lord Voldemort, it was that-which-shall-not-be-named. One could not ascribe ill effects to the drug. Now clinicians, who for many years have suspected their patient may have been injured by the drug, feel more comfortable coming forward now that there are tangible steps being taken to sponsor studies.
I think a formal outreach program has the benefit of clearly articulating to the military, to veterans workers, and to clinicians that the government takes this seriously, that the government will support you when you propose that an individual soldier may have been injured by the drug. Also, it has the practical benefit of giving veterans and soldiers information they may not have heard. Social media and regular media go only so far. I think many more veterans could be reached through such a program.